title: Sitagliptin--another option for managing type 2 diabetes in dialysis patients?
authors.forename: Wendy L
authors.initials: WL
authors.lastname: St Peter
authors.forename: Eric D
authors.initials: ED
authors.lastname: Weinhandl
authors.forename: Michael F
authors.initials: MF
authors.lastname: Flessner
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use*; D006801:Humans; D011719:Pyrazines / Q000627:therapeutic use*; D000068900:Sitagliptin Phosphate; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D011719:Pyrazines; D014230:Triazoles; D000068900:Sitagliptin Phosphate